Form 4: ReposiTrak CEO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock in March 2026 under a pre-arranged Rule 10b5-1 trading plan for charitable commitments.

Summary

  • Randall K. Fields, Chief Executive Officer, Director, and 10% Owner of ReposiTrak, Inc. (TRAK), reported sales of common stock.
  • On March 16, 2026, 6,072 shares of common stock were sold at a weighted average price of $8.0466 per share.
  • On March 17, 2026, an additional 1,428 shares of common stock were sold at a weighted average price of $8.048 per share.
  • The total number of shares sold across both transactions was 7,500.
  • These sales were executed automatically pursuant to a Rule 10b5-1 trading plan established by Mr. Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
  • The purpose of the trading plan was to enable Mr. Fields to meet some of his charitable commitments.
  • Following these transactions, Mr. Fields directly owns 3,483,955 shares of common stock.
  • Indirect beneficial ownership includes 77,500 shares of common stock by RK Fields Charitable 2022, LLC, 615,260 shares of common stock by Riverview Financial Corp., 30,667 shares of common stock by Spouse, and 333,643 shares of common stock by Fields Management, Inc.
  • Indirect beneficial ownership also includes 169,797 shares of Series B Preferred Stock by Riverview Financial Corp. and 3,704 shares of Series B Preferred Stock by Spouse.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it represents insider selling, the execution under a Rule 10b5-1 plan for charitable purposes indicates a pre-planned, non-opportunistic transaction, which is generally well-received for its transparency.

Positives

  • The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating transparency and a structured approach to insider transactions, which mitigates concerns about opportunistic selling.
  • The stated reason for the sales is to meet charitable commitments, which can be viewed positively regarding the reporting person's philanthropic activities.

Negatives

  • Insider selling, even if pre-planned, can sometimes be perceived by some investors as a signal, although the charitable purpose and 10b5-1 plan significantly reduce this interpretation.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

  • "The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC. The Trading Plan was established to enable the Reporting Person to meet some of his charitable commitments."

Industry Context

StockSavvy.ai notes that Rule 10b5-1 trading plans are a common and legally compliant mechanism for corporate insiders to sell company stock. These plans allow insiders to pre-arrange sales at a future date, providing an affirmative defense against claims of insider trading and offering transparency to the market. Such plans are widely used across various industries to manage personal liquidity, diversification, or, as in this case, charitable commitments, without being subject to real-time market influence.

Related Party Transactions

  • The sales were made by Randall K. Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC, which is a related entity.

Stakeholder Impact

  • Shareholders: The impact on shareholders is likely minimal given the relatively small number of shares sold (7,500) and the pre-planned nature of the transaction under a 10b5-1 plan for charitable purposes. It does not suggest a lack of confidence in the company's future.
  • Employees: No direct impact on employees is indicated by this filing.
  • Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

DateDescription
03/16/2026Transaction date for the sale of 6,072 shares of common stock.
03/17/2026Transaction date for the sale of 1,428 shares of common stock.
03/18/2026Date the Form 4 was signed by Randall K. Fields.

Recommendation

hold

This Form 4 filing reports a routine, pre-planned insider stock sale for charitable purposes. It does not provide new fundamental information about ReposiTrak's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The sale is small relative to the insider's total holdings and the company's market capitalization, and the 10b5-1 plan mitigates any negative signaling. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific transaction.

Keywords

ReposiTrak, TRAK, Randall K. Fields, Insider Sale, Form 4, 10b5-1 Plan, Common Stock, CEO, Director, 10% Owner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.